NYSE:FLUT
NYSE:FLUTHospitality

3 Stocks Estimated To Be Up To 48.4% Below Intrinsic Value

As the U.S. stock market reaches new heights, driven by geopolitical events and a surge in energy shares, investors are increasingly looking for opportunities in undervalued stocks that may offer significant potential. In this environment, identifying stocks trading below their intrinsic value can be a strategic move for those seeking to capitalize on market inefficiencies and future growth prospects.
NasdaqGM:FLY
NasdaqGM:FLYAerospace & Defense

3 Growth Companies With High Insider Ownership And Up To 49% Revenue Growth

As the U.S. stock market experiences a surge, with major indices like the Dow Jones and S&P 500 climbing sharply following geopolitical developments, investors are increasingly focused on identifying growth opportunities amidst this volatility. In such an environment, companies with high insider ownership can be particularly appealing as they often indicate strong confidence from those closest to the business, aligning well with current market dynamics that favor robust revenue growth potential.
NasdaqCM:RPID
NasdaqCM:RPIDLife Sciences

3 Penny Stocks With Market Caps Under $200M To Watch

The U.S. stock market has been experiencing a surge, with major indices like the Dow Jones hitting all-time highs, driven by geopolitical developments and strong performances in sectors such as energy. For investors willing to explore beyond the well-known giants, penny stocks—often representing smaller or emerging companies—can present intriguing opportunities. Despite being an older term, these stocks remain relevant for those seeking potential value in less-established firms with solid...
NasdaqCM:ISBA
NasdaqCM:ISBABanks

Undiscovered Gems in the US Market to Explore This January 2026

As the U.S. market kicks off 2026, major indices like the Dow Jones and S&P 500 are experiencing significant gains, buoyed by geopolitical events such as the capture of Venezuelan President Maduro. Amidst this backdrop of rising energy shares and fluctuating economic indicators, investors may find opportunities in lesser-known stocks that exhibit strong fundamentals and potential for growth within a dynamic market environment.
NYSE:NBHC
NYSE:NBHCBanks

Top Dividend Stocks To Consider In January 2026

As the U.S. stock market experiences a surge following geopolitical developments, particularly with energy shares leading the charge, investors are keenly observing how these dynamics might influence their portfolios. In such a volatile environment, dividend stocks often stand out as attractive options due to their potential for providing steady income and relative stability amidst market fluctuations.
NasdaqGS:INCY
NasdaqGS:INCYBiotechs

The Bull Case For Incyte (INCY) Could Change Following Positive frontMIND Phase 3 DLBCL Results

In early January 2026, Incyte reported positive topline Phase 3 frontMIND results showing that adding tafasitamab (Monjuvi/Minjuvi) and lenalidomide to R-CHOP improved progression-free survival versus R-CHOP alone in newly diagnosed high-risk diffuse large B-cell lymphoma, with no new safety signals observed. This outcome strengthens tafasitamab’s profile beyond its existing relapsed or refractory follicular lymphoma approvals and sets up a planned supplemental Biologics License Application...
NasdaqGS:DDOG
NasdaqGS:DDOGSoftware

Assessing Datadog (DDOG) Valuation After Recent Share Price Weakness

Datadog stock snapshot Datadog (DDOG), a US based observability and security platform provider, has drawn attention after recent share price weakness, with returns negative over the past week, month and past 3 months. See our latest analysis for Datadog. That recent share price weakness sits against a mixed backdrop, with Datadog’s 1 year total shareholder return of an 8.4% decline contrasting with a 3 year total shareholder return of about 2x. This suggests momentum has faded in the short...
NYSE:OGS
NYSE:OGSGas Utilities

A Look At ONE Gas (OGS) Valuation After A Year Of 18.35% Total Shareholder Return

ONE Gas (OGS) has been drawing attention after its recent share performance, with the stock roughly flat year to date but showing an 18.35% total return over the past year. See our latest analysis for ONE Gas. ONE Gas’s recent share price has eased back over the past quarter, yet the 1 year total shareholder return of 18.35% suggests momentum has been building rather than fading. If you are weighing ONE Gas against other utilities, it can also be useful to look beyond the sector and see how...
NasdaqGS:WYNN
NasdaqGS:WYNNHospitality

Assessing Wynn Resorts (WYNN) Valuation After Recent Price Consolidation And Macau UAE Growth Narrative

Wynn Resorts (WYNN) is back on traders’ radar after its recent price move, with the stock closing at $122.57. For investors, the key question is how current performance lines up with its fundamentals. See our latest analysis for Wynn Resorts. The recent 1.9% 1 day share price return and relatively flat 90 day share price performance sit alongside a 1 year total shareholder return of 46.3%. This points to momentum that has been strong over the longer stretch, even as near term moves have been...
NYSE:ARES
NYSE:ARESCapital Markets

A Look At Ares Management’s Valuation As Fundraising And Private Credit Pipeline Gain Momentum

Ares Management (ARES) is back in the spotlight after reports of fresh fundraising milestones across its flagship credit and private equity platforms, as well as continued deployment into private credit deals as traditional lenders step back. See our latest analysis for Ares Management. The latest fundraising headlines come against a backdrop of a US$166.33 share price, with a 1-day share price return of 2.91% and a 90-day share price return of 11.90%. At the same time, the 1-year total...
NYSE:O
NYSE:ORetail REITs

Is Realty Income (O) Offering A Long Term Opportunity After Recent Price Pullback

If you are looking at Realty Income and wondering whether its current price reflects fair value or an opportunity, this article will help you make sense of where it stands today. The stock most recently closed at US$57.31, with returns of 0.9% over 7 days, a 2.0% decline over 30 days, flat performance year to date, and 15.0% over 1 year. These moves may have shifted how some investors see its risk and return profile. Recent news flow around Realty Income has largely centered on its role as a...
NasdaqGS:WTFC
NasdaqGS:WTFCBanks

Wintrust Financial (WTFC) Valuation Check After Recent Share Price Momentum And DCF Discount

Wintrust Financial (WTFC) has drawn investor attention recently as its shares trade around $142.66, while reported return figures over the past year and past 3 months give a snapshot of how the stock has behaved. See our latest analysis for Wintrust Financial. The recent 1 day share price return of 2.03% and 90 day share price return of 8.35% suggest momentum has been building. The 1 year total shareholder return of 13.55% and 5 year total shareholder return of 136.89% point to a stronger...
NasdaqGS:ASTE
NasdaqGS:ASTEMachinery

Astec Industries (ASTE) Valuation Check After Recent Share Price Move And TerraSource Acquisition

Astec Industries (ASTE) has drawn investor attention after recent share price moves, with the stock up about 3% over the past day while showing a decline over the past 3 months. See our latest analysis for Astec Industries. That 3.02% 1 day share price return comes after a softer patch, with a 90 day share price return of 6.06% and year to date performance around flat. The 1 year total shareholder return of 36.06% points to momentum that has cooled more recently. If Astec’s moves have you...
NasdaqGS:WDAY
NasdaqGS:WDAYSoftware

Assessing Workday (WDAY) Valuation After Sustainable Growth Advisers Fully Exits The Stock

Sustainable Growth Advisers’ decision to fully exit Workday (WDAY), citing tougher competition from SAP and expectations for slower revenue growth, has put the stock back in focus for investors assessing long term prospects. See our latest analysis for Workday. Workday’s recent share price weakness, including a 1 day share price return of 4.19% decline and a 90 day share price return of 11.74% decline to US$205.79, sits alongside a 1 year total shareholder return of 19.02% decline and a 3...
NasdaqGS:SBRA
NasdaqGS:SBRAHealth Care REITs

A Look At Sabra Health Care REIT (SBRA) Valuation After CIO Transition To Darrin Smith

Sabra Health Care REIT (SBRA) is in focus after a leadership transition in its investment team, as long-serving CIO Talya Nevo-Hacohen retired and Darrin Smith stepped into the CIO, Secretary, and Executive Vice President roles. See our latest analysis for Sabra Health Care REIT. At a share price of $19.15, Sabra Health Care REIT has seen a 6.33% 90 day share price return. Its 1 year total shareholder return of 23.23% and 3 year total shareholder return of 88.03% indicate that momentum has...
NYSE:AVB
NYSE:AVBResidential REITs

A Look At AvalonBay Communities (AVB) Valuation Following Recent Share Price Moves

AvalonBay Communities (AVB) is back on investors’ radar after its recent share move, with the stock around $180.48 and showing mixed total returns over the past year, month, and past 3 months. See our latest analysis for AvalonBay Communities. That recent move around the US$180.48 share price comes after a 1 year total shareholder return decline of 12.12%, while 3 and 5 year total shareholder returns of 23.50% and 35.69% suggest momentum has been uneven rather than firmly building or...
NasdaqGS:PLAB
NasdaqGS:PLABSemiconductor

The Bull Case For Photronics (PLAB) Could Change Following CTO Transition To Possible Advisory Role

Photronics, Inc. announced that Dr. Christopher Progler, its longtime Executive Vice President and Chief Technology Officer, stepped away from his role on December 29, 2025, following more than 20 years with the company. His possible shift into an advisory capacity raises important questions about how Photronics will sustain its technology roadmap and innovation leadership without him in the day-to-day role. Next, we’ll examine how this CTO transition, and the potential advisory arrangement,...
NYSE:MET
NYSE:METInsurance

Is MetLife (MET) Pricing Reflect Its Earnings Power And Excess Returns Today

If you are wondering whether MetLife is priced fairly today or if there is still value on the table, you are in the right place. MetLife recently closed at US$80.32, with returns of 0.4% over 7 days, 2.1% over 30 days, 0.0% year to date, 0.8% over 1 year, 23.5% over 3 years and 89.7% over 5 years. This gives useful context before lining that price up against its fundamentals. Recent coverage has focused on MetLife's position as a major US insurer and how it fits into broader discussions...
NYSE:TDY
NYSE:TDYElectronic

A Look At Teledyne Technologies (TDY) Valuation After FLIR Tura Thermal Camera Launch

Teledyne Technologies (TDY) is back in focus after its Teledyne FLIR OEM unit launched Tura, an automotive grade thermal infrared camera built to ASIL-B and ISO 26262 safety standards for ADAS and autonomous vehicles. See our latest analysis for Teledyne Technologies. Teledyne’s Tura launch and recent board changes come as the stock trades at $518.77, with a 1-day share price return of 1.57%, a 90-day share price return decline of 11.86%, and a 1-year total shareholder return of 13.89%. This...
NYSE:PSN
NYSE:PSNProfessional Services

How Investors May Respond To Parsons (PSN) Securing A Decade-Long $392 Million Federal Biometrics Deal

Parsons Corporation recently announced it was awarded a ten-year, US$392 million single-award contract by a Federal customer, expanding its biometrics and network engineering work supporting identity management and threat detection for defense and law enforcement missions. This win reinforces Parsons’ position in advanced biometrics solutions, where it has already deployed more than 3,500 mobile systems for real-time identity verification in critical operations. We’ll now examine how this...
NasdaqCM:SLNO
NasdaqCM:SLNOBiotechs

A Look At Soleno Therapeutics (SLNO) Valuation After Pivotal VYKAT XR Study Publication And FDA Approval

Soleno Therapeutics (SLNO) is back in focus after publishing Phase 3 withdrawal study results for VYKAT XR in the Journal of Clinical Endocrinology and Metabolism. This reinforces the dataset that supported U.S. FDA approval for hyperphagia in Prader Willi syndrome. See our latest analysis for Soleno Therapeutics. The publication of the VYKAT XR Phase 3 withdrawal data comes after a mixed stretch for the shares, with a 30 day share price return of an 8.18% decline and a very large 3 year...
NYSEAM:GROY
NYSEAM:GROYMetals and Mining

Will Viral Interest in Gold Royalty's Asset-Light Model Change Gold Royalty's (GROY) Narrative?

Gold Royalty Corp has recently drawn viral attention for its micro-cap gold royalty and streaming model, which offers exposure to gold production without owning or operating mines directly. This surge in interest highlights how some investors are seeking asset-light ways to participate in the gold sector while accepting higher volatility and project-dependent risk. Next, we’ll explore how this heightened focus on Gold Royalty’s asset-light royalty model affects its existing investment...